Search research articles
Contact Us
Filters
Showing results (51-60 of 129) with videos related to
Page
of 13
Sort By:
Journal of Translational Medicine
|
December 24, 2003
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
Michele Guida, Alessandra Ravaioli, Vanna Chiarion Sileni, et al.
Journal of Translational Medicine
|
December 11, 2020
Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma
Sabino Strippoli, Livia Fucci, Antonio Negri, et al.
Frontiers in Immunology
|
May 27, 2024
Case report: Is severe toxicity the price to pay for high sensitivity to checkpoint inhibitors immunotherapy in desmoplastic melanoma?
Teresa Squicciarini, Rossella Villani, Benedetta Apollonio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial
Ruggero Ridolfi, Vanna Chiarion-Sileni, Michele Guida, et al.
Journal of Environmental Radioactivity
|
February 3, 2026
Environmental and health risk assessment of radon in Capodifiume Lake: Investigating elevated radon levels in a karst aquifer system
Michele Guida, Simona Mancini, Serpil Akӧzcan Pehlivanoğlu, et al.
Journal for Immunotherapy of Cancer
|
May 11, 2021
uPAR<sup>+</sup> extracellular vesicles: a robust biomarker of resistance to checkpoint inhibitor immunotherapy in metastatic melanoma patients
Letizia Porcelli, Michele Guida, Simona De Summa, et al.
Journal of Translational Medicine
|
September 20, 2019
Correction to: New paradigm for stage III melanoma: from surgery to adjuvant treatment
Paolo Antonio Ascierto, Lorenzo Borgognoni, Gerardo Botti, et al.
Journal of Translational Medicine
|
August 16, 2019
New paradigm for stage III melanoma: from surgery to adjuvant treatment
Paolo Antonio Ascierto, Lorenzo Borgognoni, Gerardo Botti, et al.
Oncology Reports
|
November 8, 2005
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial
Vito Lorusso, Vittorio Gebbia, Massimiliano Spada, et al.
Pigment Cell & Melanoma Research
|
August 20, 2016
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors
Michele Guida, Sabino Strippoli, Anna Ferretta, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 129) with videos related to
Sort By:
Page
of 13
Journal of Translational Medicine
|
December 24, 2003
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
Michele Guida, Alessandra Ravaioli, Vanna Chiarion Sileni, et al.
Journal of Translational Medicine
|
December 11, 2020
Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma
Sabino Strippoli, Livia Fucci, Antonio Negri, et al.
Frontiers in Immunology
|
May 27, 2024
Case report: Is severe toxicity the price to pay for high sensitivity to checkpoint inhibitors immunotherapy in desmoplastic melanoma?
Teresa Squicciarini, Rossella Villani, Benedetta Apollonio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial
Ruggero Ridolfi, Vanna Chiarion-Sileni, Michele Guida, et al.
Journal of Environmental Radioactivity
|
February 3, 2026
Environmental and health risk assessment of radon in Capodifiume Lake: Investigating elevated radon levels in a karst aquifer system
Michele Guida, Simona Mancini, Serpil Akӧzcan Pehlivanoğlu, et al.
Journal for Immunotherapy of Cancer
|
May 11, 2021
uPAR<sup>+</sup> extracellular vesicles: a robust biomarker of resistance to checkpoint inhibitor immunotherapy in metastatic melanoma patients
Letizia Porcelli, Michele Guida, Simona De Summa, et al.
Journal of Translational Medicine
|
September 20, 2019
Correction to: New paradigm for stage III melanoma: from surgery to adjuvant treatment
Paolo Antonio Ascierto, Lorenzo Borgognoni, Gerardo Botti, et al.
Journal of Translational Medicine
|
August 16, 2019
New paradigm for stage III melanoma: from surgery to adjuvant treatment
Paolo Antonio Ascierto, Lorenzo Borgognoni, Gerardo Botti, et al.
Oncology Reports
|
November 8, 2005
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial
Vito Lorusso, Vittorio Gebbia, Massimiliano Spada, et al.
Pigment Cell & Melanoma Research
|
August 20, 2016
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors
Michele Guida, Sabino Strippoli, Anna Ferretta, et al.
Page
of 13